Skip to main content
DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.41
+1.54 (31.62%)
At close: Dec 20, 2024, 4:00 PM
5.65
-0.76 (-11.86%)
After-hours: Dec 20, 2024, 7:58 PM EST

DiaMedica Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
19
Market Cap
274.10M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
biote 193.06M
LifeMD 193.06M
ADC Therapeutics 70.72M
SOPHiA GENETICS 64.49M
Utah Medical Products 44.08M
Zentalis Pharmaceuticals 40.56M
Inhibrx Biosciences 1.57M
Revenue Rankings

DMAC News

More News